-
ImmusanT to develop Type 1 diabetes vaccine with JDRF backing
fiercebiotech
September 12, 2018
JDRF plans to do more than just support ImmusanT with a VC investment, and will engage in a collaboration on the project.
-
A Review of the Vaccines Marketed in China: 63 Varieties of Vaccines from 45 Enterprises
1℃
August 10, 2018
The vaccine incident of Changsheng Bio-technology has continued to simmer recently. Vaccine fabrication is something absolutely intolerable.
-
Online information on vaccines and autism not always reliable, study shows
worldpharmanews
June 20, 2018
Research at Brighton and Sussex Medical School (BSMS) has found that information available online can provide unreliable information based on old, 'weak' scientific studies. The study 'Fake news or weak science?' is published in open-access journal Fronti
-
Sanofi Pasteur and Translate Bio to develop new mRNA vaccines
pharmaceutical-technology
June 13, 2018
Global vaccine company Sanofi Pasteur has signed a research and development (R&D) collaboration and exclusive licensing agreement with therapeutics company Translate Bio to develop new vaccines using mRNA technology.
-
Sri Lanka to register two foreign cancer vaccines
biospectrumasia
June 08, 2018
The Russian vaccine ‘Hearticad’ which was brought down by the minister was rejected by the Sri Lanka College of Oncologists.
-
Roche's multiple sclerosis drug Ocrevus lowered patients' vaccine responses: study
fiercepharma
June 07, 2018
Roche’s multiple sclerosis newcomer Ocrevus was approved by the FDA last March bearing a warning about immunization.
-
Where is Pfizer putting its R&D hopes? Vaccines are front and center
fiercevaccines
May 17, 2018
On Pfizer’s first-quarter earnings call, CEO Ian Read drew up a long list of R&D programs the company’s expecting to drive future growth.
-
Where is Pfizer putting its R&D hopes? Vaccines are front and center
fiercepharma
May 08, 2018
On Pfizer’s first-quarter earnings call, CEO Ian Read drew up a long list of R&D programs the company’s expecting to drive future growth. But when Bernstein analyst Tim Anderson asked him to narrow it down, Read mentioned vaccines first.
-
GSK's Shingrix blows past sales projections, pushing 2018 estimates to $600M
fiercepharma
May 02, 2018
GlaxoSmithKline's Shingrix carried high expectations, but it turns out that those ambitious projections weren't high enough.
-
WHO South-East Asia emphasizes on life-saving vaccines
biospectrumasia
April 23, 2018
At present, seven Member countries’ routine immunization programmes have achieved more than 90% coverage with three doses of the basic diphtheria, tetanus and pertussis vaccine
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
